Eribulin Mesylate Injection

Product description

Eribulin Mesylate Injection is used to treat certain patients with breast cancer and liposarcoma.

Strength: 1mg/2ml

This product is still in R & D stage.
Read more

Specifications

Categories Finished Dosage FormsInjectables; Finished Dosage Forms
Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America

More products from Jiangsu Hengrui Medicine Co., Ltd.

View all our products (78)

Products from other suppliers

Eribulin Mesylate Injection

Contact information

Address

Telephone

Website

View all contact information